MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions
View by Date

Sunday, October 7, 2018

1:45pm-3:15pm
Metabolomic Profiling of Activated Microglial Cells

V. Vedam-Mai, T. Domenick, E. Gill, T. Garrett, R. Yost, M. Okun (Gainesville, FL, USA)

Other  ·  Hall 3FG
1:45pm-3:15pm
Methylphenidate in Progressive Supranuclear Palsy [PSP] – Old drug, New Indications?

N. Sawal, P. Bansal, R. Gupta (Chandigarh, India)

Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus)  ·  Hall 3FG
1:45pm-3:15pm
mGluR1 antibodies encephalitis: A rare cause of reversible ataxia and myoclonus syndrome

F. Ory Magne, C. Goillion, J. Dupouy, M. Simonetta, C. Brefel Courbon, O. Rascol, J. (Toulouse, France)

Ataxia  ·  Hall 3FG
1:45pm-3:15pm
MicroRNAs Unveil Metabolic Imbalance in Spinocerebellar Ataxia Type-2

V. Swarup, R. Singh, H. Singh, I. Singh, M. Faruq, S. Vivekanandhan, A. Srivastava (New Delhi, India)

Ataxia  ·  Hall 3FG
1:45pm-3:15pm
Midbrain Diameter Measurements on High-Resolution Computer Tomography Scans to aid diagnosis of Progressive Supranuclear Palsy

S. Potluri, C. Gan, C. Thomas, B. Mohamed, S. Schwarz (Cardiff, United Kingdom)

Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus)  ·  Hall 3FG
1:45pm-3:15pm
Midbrain/pons area ratio and clinical features predict the prognosis of PSP

S. Cui, S. Chen (Shanghai, People’s Republic of China)

Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus)  ·  Hall 3FG
1:45pm-3:15pm
Mingo Supplement Trial: An Open-Labeled Randomized-Controlled Trial in X-linked Dystonia-Parkinsonism patients in the Province of Capiz, Philippines

P. Acuna, G. Solinap, M. Ang, J. de Guzman, C. Go (Charlestown, MA, USA)

Dystonia  ·  Hall 3FG
1:45pm-3:15pm
Models of Parkinson’s disease in vitro

A. Dilzoda (Tashkent, Uzbekistan)

Other  ·  Hall 3FG
1:45pm-3:15pm
Mortality from Parkinson’s disease in China: Findings from a Ten-year follow up study in Shanghai

G. Wang, G. Xu, YQ. Zhang, SD. Chen (Shanghai, China)

Epidemiology  ·  Hall 3FG
1:45pm-3:15pm
Motivators, Barriers and Clinical Correlates of Physical Activity in Parkinson Disease

S. Mantri, S. Wood, J. Duda, J. Morley (Philadelphia, PA, USA)

Technology  ·  Hall 3FG
  • «Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • …
  • 60
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley